Entry |
|
Symbol |
MAP2K1, CFC3, MAPKK1, MEK1, MEL, MKK1, PRKMK1
|
Name |
(RefSeq) mitogen-activated protein kinase kinase 1
|
KO |
|
Organism |
|
Pathway |
hsa01521 | EGFR tyrosine kinase inhibitor resistance |
hsa04072 | Phospholipase D signaling pathway |
hsa04270 | Vascular smooth muscle contraction |
hsa04550 | Signaling pathways regulating pluripotency of stem cells |
hsa04613 | Neutrophil extracellular trap formation |
hsa04620 | Toll-like receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa04664 | Fc epsilon RI signaling pathway |
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa04810 | Regulation of actin cytoskeleton |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04919 | Thyroid hormone signaling pathway |
hsa04928 | Parathyroid hormone synthesis, secretion and action |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa05022 | Pathways of neurodegeneration - multiple diseases |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
hsa05208 | Chemical carcinogenesis - reactive oxygen species |
hsa05230 | Central carbon metabolism in cancer |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Network |
|
Element |
N00001 | EGF-EGFR-RAS-ERK signaling pathway |
N00002 | BCR-ABL fusion kinase to RAS-ERK signaling pathway |
N00003 | Mutation-activated KIT to RAS-ERK signaling pathway |
N00004 | Duplication or mutation-activated FLT3 to RAS-ERK signaling pathway |
N00005 | Mutation-activated MET to RAS-ERK signaling pathway |
N00006 | Amplified EGFR to RAS-ERK signaling pathway |
N00007 | EML4-ALK fusion kinase to RAS-ERK signaling pathway |
N00008 | RET fusion kinase to RAS-ERK signaling pathway |
N00009 | TRK fusion kinase to RAS-ERK signaling pathway |
N00011 | Mutation-activated FGFR3 to RAS-ERK signaling pathway |
N00012 | Mutation-activated KRAS/NRAS to ERK signaling pathway |
N00013 | Mutation-activated BRAF to ERK signaling pathway |
N00014 | Mutation-activated EGFR to RAS-ERK signaling pathway |
N00015 | PDGF-PDGFR-RAS-ERK signaling pathway |
N00016 | PDGF-overexpression to RAS-ERK signaling pathway |
N00018 | Amplified PDGFR to RAS-ERK signaling pathway |
N00019 | FGF-FGFR-RAS-ERK signaling pathway |
N00020 | Amplified FGFR to RAS-ERK signaling pathway |
N00021 | EGF-ERBB2-RAS-ERK signaling pathway |
N00022 | ERBB2-overexpression to RAS-ERK signaling pathway |
N00023 | EGF-EGFR-PLCG-ERK signaling pathway |
N00024 | Mutation-activated EGFR to PLCG-ERK signaling pathway |
N00025 | EML4-ALK fusion kinase to PLCG-ERK signaling pathway |
N00041 | EGFR-overexpression to RAS-ERK signaling pathway |
N00077 | HRAS-overexpression to ERK signaling pathway |
N00078 | Mutation-activated HRAS to ERK signaling pathway |
N00152 | CXCR-GNB/G-ERK signaling pathway |
N00215 | KITLG-KIT-RAS-ERK signaling pathway |
N00216 | HGF-MET-RAS-ERK signaling pathway |
N00217 | FLT3LG-FLT3-RAS-ERK signaling pathway |
N00229 | TGFA-EGFR-RAS-ERK signaling pathway |
N00230 | TGFA-overexpression to RAS-ERK signaling pathway |
N00233 | IGF-IGF1R-RAS-ERK signaling pathway |
N00235 | IGF2-overexpression to RAS-ERK signaling pathway |
N00237 | IGF1R-overexpression to RAS-ERK signaling pathway |
N00246 | HGF-overexpression to RAS-ERK signaling pathway |
N00248 | MET-overexpression to RAS-ERK signaling pathway |
N00252 | Amplified ERBB2 to RAS-ERK signaling pathway |
N00259 | Amplified MET to RAS-ERK signaling pathway |
N00276 | EGF-overexpression to RAS-ERK signaling pathway |
N00277 | EREG-EGFR-RAS-ERK signaling pathway |
N00278 | EREG-overexpression to RAS-ERK signaling pathway |
N00279 | AREG-EGFR-RAS-ERK signaling pathway |
N00280 | AREG-overexpression to RAS-ERK signaling pathway |
N00367 | HPV E5 to EGFR-RAS-ERK signaling pathway |
N00386 | HCMV gB to PDGFR-RAS-ERK signaling pathway |
N00438 | TLR2/4-MAPK signaling pathway |
N00513 | Mutation-activated EGFR to RAS-ERK signaling pathway |
N00518 | HCV Core to ERK signaling pathway |
N00519 | HCV Core to ERK signaling pathway |
N00538 | Ca2+-PYK2-RAS-ERK signaling pathway |
N00540 | HBV HBx to RAS-ERK signaling pathway |
N00546 | CXCL12-CXCR4-PKC-ERK signaling pathaway |
N00862 | Yersinia YopP/J to TLR2/4-MAPK signaling pathway |
N00873 | GnRH-GnRHR-PLCB-PKC signaling pathway |
N00994 | AGE-RAGE signaling pathway |
N00996 | Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway |
N01062 | Mutation-activated MET to RAS-ERK signaling pathway |
N01064 | Mutation-activated RET to RAS-ERK signaling pathway |
N01119 | RAC/CDC42-PAK-ERK signaling pathway |
N01343 | ACH-CHRN-RAS-ERK signaling pathway |
N01344 | NNK/NNN to RAS-ERK signaling pathway |
N01351 | E2-ER-RAS-ERK signaling pathway |
N01352 | BPA to RAS-ERK signaling pathway |
N01353 | E2 to RAS-ERK signaling pathway |
N01354 | BPA to RAS-ERK signaling pathway |
N01360 | P4-PR-RAS-ERK signaling pathway |
N01361 | P4/MPA to PR-RAS-ERK signaling pathway |
N01408 | Metals to RAS-ERK signaling pathway |
N01592 | GF-RTK-RAS-ERK signaling pathway |
|
Disease |
H00523 | Noonan syndrome and related disorders |
H01512 | Langerhans cell histiocytosis |
H01745 | Cardiofaciocutaneous syndrome |
H02425 | Erdheim-Chester disease |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
5604 (MAP2K1)
04012 ErbB signaling pathway
5604 (MAP2K1)
04014 Ras signaling pathway
5604 (MAP2K1)
04015 Rap1 signaling pathway
5604 (MAP2K1)
04370 VEGF signaling pathway
5604 (MAP2K1)
04371 Apelin signaling pathway
5604 (MAP2K1)
04668 TNF signaling pathway
5604 (MAP2K1)
04066 HIF-1 signaling pathway
5604 (MAP2K1)
04068 FoxO signaling pathway
5604 (MAP2K1)
04072 Phospholipase D signaling pathway
5604 (MAP2K1)
04071 Sphingolipid signaling pathway
5604 (MAP2K1)
04024 cAMP signaling pathway
5604 (MAP2K1)
04022 cGMP-PKG signaling pathway
5604 (MAP2K1)
04151 PI3K-Akt signaling pathway
5604 (MAP2K1)
04150 mTOR signaling pathway
5604 (MAP2K1)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
5604 (MAP2K1)
04148 Efferocytosis
5604 (MAP2K1)
09143 Cell growth and death
04114 Oocyte meiosis
5604 (MAP2K1)
04210 Apoptosis
5604 (MAP2K1)
04218 Cellular senescence
5604 (MAP2K1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
5604 (MAP2K1)
04540 Gap junction
5604 (MAP2K1)
04550 Signaling pathways regulating pluripotency of stem cells
5604 (MAP2K1)
09142 Cell motility
04810 Regulation of actin cytoskeleton
5604 (MAP2K1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
5604 (MAP2K1)
04620 Toll-like receptor signaling pathway
5604 (MAP2K1)
04650 Natural killer cell mediated cytotoxicity
5604 (MAP2K1)
04660 T cell receptor signaling pathway
5604 (MAP2K1)
04662 B cell receptor signaling pathway
5604 (MAP2K1)
04664 Fc epsilon RI signaling pathway
5604 (MAP2K1)
04666 Fc gamma R-mediated phagocytosis
5604 (MAP2K1)
04062 Chemokine signaling pathway
5604 (MAP2K1)
09152 Endocrine system
04910 Insulin signaling pathway
5604 (MAP2K1)
04929 GnRH secretion
5604 (MAP2K1)
04912 GnRH signaling pathway
5604 (MAP2K1)
04915 Estrogen signaling pathway
5604 (MAP2K1)
04914 Progesterone-mediated oocyte maturation
5604 (MAP2K1)
04917 Prolactin signaling pathway
5604 (MAP2K1)
04921 Oxytocin signaling pathway
5604 (MAP2K1)
04926 Relaxin signaling pathway
5604 (MAP2K1)
04935 Growth hormone synthesis, secretion and action
5604 (MAP2K1)
04919 Thyroid hormone signaling pathway
5604 (MAP2K1)
04928 Parathyroid hormone synthesis, secretion and action
5604 (MAP2K1)
04916 Melanogenesis
5604 (MAP2K1)
09153 Circulatory system
04270 Vascular smooth muscle contraction
5604 (MAP2K1)
09156 Nervous system
04725 Cholinergic synapse
5604 (MAP2K1)
04726 Serotonergic synapse
5604 (MAP2K1)
04720 Long-term potentiation
5604 (MAP2K1)
04730 Long-term depression
5604 (MAP2K1)
04722 Neurotrophin signaling pathway
5604 (MAP2K1)
09158 Development and regeneration
04380 Osteoclast differentiation
5604 (MAP2K1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
5604 (MAP2K1)
05206 MicroRNAs in cancer
5604 (MAP2K1)
05205 Proteoglycans in cancer
5604 (MAP2K1)
05207 Chemical carcinogenesis - receptor activation
5604 (MAP2K1)
05208 Chemical carcinogenesis - reactive oxygen species
5604 (MAP2K1)
05230 Central carbon metabolism in cancer
5604 (MAP2K1)
05231 Choline metabolism in cancer
5604 (MAP2K1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
5604 (MAP2K1)
09162 Cancer: specific types
05210 Colorectal cancer
5604 (MAP2K1)
05212 Pancreatic cancer
5604 (MAP2K1)
05225 Hepatocellular carcinoma
5604 (MAP2K1)
05226 Gastric cancer
5604 (MAP2K1)
05214 Glioma
5604 (MAP2K1)
05216 Thyroid cancer
5604 (MAP2K1)
05221 Acute myeloid leukemia
5604 (MAP2K1)
05220 Chronic myeloid leukemia
5604 (MAP2K1)
05218 Melanoma
5604 (MAP2K1)
05211 Renal cell carcinoma
5604 (MAP2K1)
05219 Bladder cancer
5604 (MAP2K1)
05215 Prostate cancer
5604 (MAP2K1)
05213 Endometrial cancer
5604 (MAP2K1)
05224 Breast cancer
5604 (MAP2K1)
05223 Non-small cell lung cancer
5604 (MAP2K1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
5604 (MAP2K1)
05170 Human immunodeficiency virus 1 infection
5604 (MAP2K1)
05161 Hepatitis B
5604 (MAP2K1)
05160 Hepatitis C
5604 (MAP2K1)
05164 Influenza A
5604 (MAP2K1)
05163 Human cytomegalovirus infection
5604 (MAP2K1)
05167 Kaposi sarcoma-associated herpesvirus infection
5604 (MAP2K1)
05165 Human papillomavirus infection
5604 (MAP2K1)
09171 Infectious disease: bacterial
05132 Salmonella infection
5604 (MAP2K1)
05135 Yersinia infection
5604 (MAP2K1)
09164 Neurodegenerative disease
05010 Alzheimer disease
5604 (MAP2K1)
05022 Pathways of neurodegeneration - multiple diseases
5604 (MAP2K1)
09165 Substance dependence
05034 Alcoholism
5604 (MAP2K1)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
5604 (MAP2K1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
5604 (MAP2K1)
01522 Endocrine resistance
5604 (MAP2K1)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:hsa01001]
5604 (MAP2K1)
Enzymes [BR:hsa01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.12 Dual-specificity kinases (those acting on Ser/Thr and Tyr residues)
2.7.12.2 mitogen-activated protein kinase kinase
5604 (MAP2K1)
Protein kinases [BR:hsa01001]
Serine/threonine kinases: STE group
STE7 family
5604 (MAP2K1)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
Position |
15:66386912..66491544
|
AA seq |
393 aa
MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQKQKV
GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE
CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL
REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY
SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY
GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF
IKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGV |
NT seq |
1182 nt +upstreamnt +downstreamnt
atgcccaagaagaagccgacgcccatccagctgaacccggcccccgacggctctgcagtt
aacgggaccagctctgcggagaccaacttggaggccttgcagaagaagctggaggagcta
gagcttgatgagcagcagcgaaagcgccttgaggcctttcttacccagaagcagaaggtg
ggagaactgaaggatgacgactttgagaagatcagtgagctgggggctggcaatggcggt
gtggtgttcaaggtctcccacaagccttctggcctggtcatggccagaaagctaattcat
ctggagatcaaacccgcaatccggaaccagatcataagggagctgcaggttctgcatgag
tgcaactctccgtacatcgtgggcttctatggtgcgttctacagcgatggcgagatcagt
atctgcatggagcacatggatggaggttctctggatcaagtcctgaagaaagctggaaga
attcctgaacaaattttaggaaaagttagcattgctgtaataaaaggcctgacatatctg
agggagaagcacaagatcatgcacagagatgtcaagccctccaacatcctagtcaactcc
cgtggggagatcaagctctgtgactttggggtcagcgggcagctcatcgactccatggcc
aactccttcgtgggcacaaggtcctacatgtcgccagaaagactccaggggactcattac
tctgtgcagtcagacatctggagcatgggactgtctctggtagagatggcggttgggagg
tatcccatccctcctccagatgccaaggagctggagctgatgtttgggtgccaggtggaa
ggagatgcggctgagaccccacccaggccaaggacccccgggaggccccttagctcatac
ggaatggacagccgacctcccatggcaatttttgagttgttggattacatagtcaacgag
cctcctccaaaactgcccagtggagtgttcagtctggaatttcaagattttgtgaataaa
tgcttaataaaaaaccccgcagagagagcagatttgaagcaactcatggttcatgctttt
atcaagagatctgatgctgaggaagtggattttgcaggttggctctgctccaccatcggc
cttaaccagcccagcacaccaacccatgctgctggcgtctaa |